28 results
424B3
wvdsc9ov3dyw6ka5z
10 Nov 21
Prospectus supplement
5:15pm
8-K
EX-99.1
m36f1ich
10 Nov 21
KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
4:12pm
8-K
s6uvgw b4wbnqm
10 Nov 21
KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
4:12pm
424B3
ycoq7ephw9cj7ov3k
11 Mar 21
Prospectus supplement
9:56pm
424B4
tpwv 3jejf2
8 Jan 21
Prospectus supplement with pricing info
9:38pm
8-K
EX-99.1
nnr8xq
5 Jan 21
Sven Guenther, Ph.D., our executive vice president, research and development; and Summary Compensation Table
9:10am
8-K
EX-10.1
gpmof9boyk9 45dr
24 Jun 20
Other Events
4:13pm